Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Hepatology. 2016 Apr 5;64(1):85–91. doi: 10.1002/hep.28514

Table 4.

Premature menopause, Time from menopause and risk of Fibrosis: subgroup analysis in patients with borderline NASH or NASH

Univariate
COR(95%CI), p-value
Model 1
COR(95%CI), p-value
Model 2
COR(95%CI), p-value
Premature menopause
No - - -
Yes 1.2 [0.9–1.8], p=0.27 1.6 [1.1–2.4], p=0.02 1.4 [0.9–2.1], p=0.11
Time from menopause, for 5 years 1.2 [1.1–1.4], p<0.0001 1.2 [1.0–1.3], p=0.01 1.1 [1.0–1.3], p=0.05

Model 1: Adjusted for age at enrollment, race, waist circumference/BMI, current smoking/alcohol use, hypertension, diabetes/IFG, HOMA-IR, and HRT.

Model 2: Adjusted for the above covariates, hepatocyte ballooning grades, and portal inflammation grades.